Your browser doesn't support javascript.
loading
Cepheid xpert monitor platform for the confirmation of BCR-ABL1 IS conversion factors for the molecular monitoring of chronic myeloid leukaemia.
Gerrard, Gareth; Foong, Hui En; Mudge, Katherine; Alikian, Mary; Apperley, Jane F; Foroni, Letizia.
Affiliation
  • Gerrard G; Centre for Haematology, Imperial College London, Du Cane Road, London W12 ONN, UK; Research Department of Pathology, UCL Cancer Institute, London WC1E 6DE, UK. Electronic address: g.gerrard@ucl.ac.uk.
  • Foong HE; Centre for Haematology, Imperial College London, Du Cane Road, London W12 ONN, UK; Imperial Molecular Pathology, Imperial Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK.
  • Mudge K; Imperial Molecular Pathology, Imperial Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK.
  • Alikian M; Centre for Haematology, Imperial College London, Du Cane Road, London W12 ONN, UK.
  • Apperley JF; Centre for Haematology, Imperial College London, Du Cane Road, London W12 ONN, UK; Imperial Molecular Pathology, Imperial Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK.
  • Foroni L; Centre for Haematology, Imperial College London, Du Cane Road, London W12 ONN, UK; Imperial Molecular Pathology, Imperial Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK.
Leuk Res ; 49: 47-50, 2016 10.
Article in En | MEDLINE | ID: mdl-27552679

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Monitoring, Physiologic Limits: Humans Language: En Journal: Leuk Res Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Monitoring, Physiologic Limits: Humans Language: En Journal: Leuk Res Year: 2016 Type: Article